unseasoned Cancer Treatment Brings Hope in 2001 by liza Jane Maltin On May 10 2001, FDA approved a new dose known as Gleevec ( pull inerly St1- 571) for successfully treating cancer of the white parentage cells known as degenerative myelogenous leukemia (CML) and a rare form of cancer that affects the stomach and intestines called gastrointestinal stromal tumors (GIST). According to Michael Heinrich, MD, an associate professor of medicine at surgery Health Sciences University in Portland and a division of the team that create Gleevec, conventional leukemia therapy like chemotherapy and radiation, kill perverted marrow cells, and in any case destroy healthy ones and thereof extremely grueling to tolerate. Gleevec, on the other hand, selectively tar conk outs an unorthodox cancer - causing protein called BCR-ABL, which causes the cancerous white blood cells to set up down out of control. Research is underway to test Gleevecs potentiality against some kinds of brain, lung, prostate, colorectal and pancreatic cancers.
Heinrich is optimistic almost the antecedent results and predicts fundamental changes non only in how we treat cancer, but also in the very way we think and talk about it. Works Citied Maltin Jane Liza, New Cancer Treatment Brings Hope in 2001. WebMD Health, Dec. 26, 2001 If you want to get a full essay, order it on our website:
OrderCustomPaper.comIf you want to get a full essay, visit our page:
write my paper
No comments:
Post a Comment